Duvuru Geetha
@DuvuruG
Followers
315
Following
1K
Statuses
421
Joined March 2016
RT @Kidney_Int: The effects of #plasmaexchange and #glucocorticoids on early kidney function among patients with #ANCA-associated #vasculit…
0
36
0
RT @edgarvlermamd: Join @goKDIGO Guideline Education Meetings (GEMS) #Nephpearls 🗓️ January 13-14, 2025 ⏰ Check your Time Zone (Europe an…
0
17
0
RT @AKronbichler: Our multi-continental study on differences in phenotypes, treatments and outcomes of AAV started as a survey to see how i…
0
3
0
RT @odlerb: Just published in @Kidney_Int - The impact of PLEX and GC on early kidney function changes in AAV. ( Th…
0
5
0
0
6
0
RT @VanjaIvkovic3: TAPIR just out at ACR comparing AAV patients with 5 mg vs. 0 mg maintenance prednisone. At M6, 5 mg offers less relapse…
0
6
0
RT @anzvasc: Excellent vasculitis sessions at #ASNKidneyWeek @ASNKidney To immerse yourself in all forms of #vasculitis to learn and work c…
0
16
0
1
0
1
RT @IzabelaZakrocka: Thank you so much @Tiff_Caza for an excellent talk about membranous nephropathy (and artwork! 👩🎨🎨) @GlomCon
https://t…
0
9
0
RT @Tobias_B_Huber: Hamburg news: Our research from teams @krebs_lab plus Ulf Panzer, and collaborators identify pathogenic T cells in ANCA…
0
7
0
0
0
2
RT @NDTsocial: Long-term outcome of kidney function in patients with ANCA-associated vasculitis 🔓
0
14
0
RT @Kidney_Int: Inhibition of complement factor C5a or C5aR for cholesterol crystal embolism–related vascular thrombosis with microvascular…
0
19
0
RT @hopkinsneph: 📄 📧 Send CV, 3 recs, & personal statement to NephrologyFellowship@jh.edu. 🔍 Queries? Contact Dr.…
0
2
0
RT @hopkinsneph: 🌟Join our Glomerular Diseases Fellowship @hopkinsneph for July 2024 - June 2025!🌟 🔬 Dive into rare diseases, research & pa…
0
7
0
RT @TheLancetRheum: NEW RESEARCH—Model-based clustering of a federated international cohort produces a data-driven subclassification of ANC…
0
26
0
RT @anzvasc: 22nd International Vasculitis Workshop, Melbourne 2026 The biggest and definitive biannual meeting of the #Vasculitis Research…
0
21
0